Human stem cell assays in immune-deficient mice

Current Opinion in Hematology

Volumn 3, Issue 6, 1996, Pages 405-409

  Dick, John E ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL MODEL; CELL POPULATION; CHRONIC MYELOID LEUKEMIA; COMBINED IMMUNODEFICIENCY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029950423     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199603060-00002     Document Type: Review

References (41)

1. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, Doren S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, et al.: Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995, 85:3048-3057.
2. Kohn D, Weinberg K, Nolta J, Heiss L, Lenarsky C, Crooks G, Hanley M, Annett G, Brooks J, El-Khoureiy A, et al.: Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Med 1995, 1:1017-1023. This study reports the first attempt at gene therapy in neonates using cord blood.
3. Kamps MP, Baltimore D: E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocyte leukemia, causes acute myeloid leukemia in mice. Mol Cell Biol 1993, 13:351-357.
4. Hawley RG, Fong AZ, Lu M, Hawley TS: The HOX11 homeobox-containing gene of human leukemia immortalizes murine hematopoietic precursors. Oncogene 1994, 9:1-12.
5. Vormoor J, Lapidot T, Larochelle A, Dick JE: Human hematopoiesis in SCID mice. In Human Hematopoiesis in SCID Mice. Edited by Roncarolo M-G, Namikawa R, Péault B. R.G. Austin, TX: Landes Company; 1995:197-212.
6. Kaneshima H, Namikawa R, McCune JM: Human hematolymphoid cells in SCID mice. Curr Opin Immunol 1994, 6:327-333.
7. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL: The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988, 241:1632-1639.
8. Dick J: Normal and leukemic stem cells assayed in SCID mice. Semin Immunol 1996, 8:197-206. This paper reviews published and unpublished evidence that human stem cells can be assayed in mice. Comparisons between different approaches are made.
9. Kamel-Reid S, Dick JE: Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 1988, 242:1706-1709.
10. Kyoizumi S, Baum CM, Kaneshima H, McCune JM, Yee EJ, Namikawa R: Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood 1992, 79:1704-1711.
11. Kyoizumi S, Murray LJ, Namikawa R: Preclinical analysis of cytokine therapy in the SCID-hu mouse. Blood 1993, 81:1479-1488.
12. Fraser CC, Kaneshima H, Hansteen G, Kilpatrick M, Hoffman R, Chen BP: Human allogeneic stem cell maintenance and differentiation in a long-term multilineage SCID-hu graft. Blood 1995, 86:1680-1693. This study reports improvement in the SCID-hu system by implanting bone, thymus, and spleen fragments. Highly purified human cells repopulate these fragments, producing multiple hematopoietic lineages.
13. Galy A, Travis M, Cen D, Chen B: Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 1995, 3:459-473.
14. Galy AH, Cen D, Travis M, Chen S, Chen BP: Delineation of T-progenitor cell activity within the CD34+ compartment of adult bone marrow. Blood 1995, 85:2770-2778.
15. Chen BP, Galy A, Kyoizumi S, Namikawa R, Scarborough J, Webb S, Ford B, Cen DZ, Chen SC: Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice. Blood 1994, 84:2497-2505.
16. Nolta JA, Hanley MB, Kohn DB: Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. Blood 1994, 83:3041-3051.
17. Bock TA, Orlic D, Dunbar CE, Broxmeyer HE, Bodine DM: Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes. J Exp Med 1995, 182:2037-2043.
18. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE: Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in scid mice. Science 1992, 255:1137-1141.
19. Shultz L, Schweitzer P, Christianson S, Gott B, Schweitzer I, Tennent B, McKenna S, Mobraaten L, Rajan T, Greiner D, Leiter E: Multiple defects in innate and adaptive immunological function in NOD/LtSz-scid mice. J Immunol 1995, 154:180-191. This paper reports the development of the NOD/SCID mouse, which is more immune deficient than SCID mice and a better recipient for human cell grafts.
20. Larochelle A, Vormoor J, Lapidot T, Sher G, Furukawa T, Li Q, Shultz L, Oliveri NF, Stamatoyannopoulos G, Dick JE: Engraftment of immune-deficient mice with primitive hematopoietic cells from β-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols. Hum Mol Genet 1995, 4:163-172. This paper reports the first development of an animal model for human hemoglobinopathies. This model serves as a paradigm to develop animal models for any genetic deficiency that affects the hematopoietic system. In addition, NOD/SCID mice were compared with SCID mice and found to be superior recipients.
21. Kollmann T, Kim A, Zhuang X, Hachamovitch M, Goldstein H: Reconstitution of SCID mice with human lymphoid and myeloid cells after transplantation with human fetal bone marrow without the requirement for exogenous human cytokines. Proc Natl Acad Sci U S A 1994, 91:8032-8036.
22. Vormoor J, Lapidot T, Pflumio F, Risdon G, Patterson B, Broxmeyer HE, Dick JE: Immature human cord blood progenitors engraft and proliferate to high levels in immune-deficient SCID mice. Blood 1994, 83:2489-2497.
23. Nolta J, Dao M, Wells S, Smogorzewska E, Kohn D: Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune deficient mice. Proc Natl Acad Sci U S A 1996, 93:2414-2419. This paper provides the first direct evidence that at least some of the human cells that engraft mice are pluripotent, whereas others are committed to a single lineage. Moreover, this paper demonstrates that the efficiency of gene transfer into the pluripotential cells is very low.
24. Fialkow P, Singer J, Raskind W, Adamson J, Jacobson R, Bernstein I, Najfeld V, Veith R: Clonal development, stem-cell differentiation, and clinical remission in acute nonlymphocytic leukemia. N Engl J Med 1987, 317:468-473.
25. Grier H, Civin C: Acute and chronic myeloproliferative disorders and myelodysplasia. In Hematology of Infancy and Childhood. Edited by Nathan D, Oski F. Philadelphia: W.B. Saunders Company; 1993:1288-1318.
26. Griffin J, Löwenberg B: Clonogenic cells in acute myeloblastic leukemia. Blood 1986, 68:1186-1195.
27. McCulloch E: Stem cell in normal and leukemic hemopoiesis (Henry Stratton Lecture). Blood 1983, 62:1.
28. Löwenberg B, Touw I: Hematopoietic growth factors and their receptors in acute leukemia. Blood 1993, 81:281-292.
29. McCulloch E, Izaguirre C, Chang L, Smith L: Renewal and determination in leukemic blast populations. J Cell Physiol 1982, 1(suppl):103-111.
30. Kamel-Reid S, Letarte M, Sirard C, Doedens M, Grunberger T, Fulop G, Freedman MH, Phillips RA, Dick JE: A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science 1989, 246:1597-1600.
31. Kamel-Reid S, Letarte M, Doedens M, Greaves A, Murdoch B, Grunberger T, Lapidot T, Thorner P, Freedman M, Phillips R, Dick J: Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in scid mice. Blood 1991, 78:2973-2981.
32. Uckun FM, Downing JR, Gunther R, Chelstrom LM, Finnegan D, Land VJ, Borowitz MJ, Carroll AJ, Crist WM: Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 1993, 81:3052-3062.
33. Uckun FM, Sather H, Reaman G, Shuster J, Land V, Trigg M, Gunther R, Chelstrom L, Bleyer A, Gaynon P, et al.: Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia. Blood 1995, 85:873-878.
34. Gunther R, Chelstrom LM, Tuel-Ahlgren L, Simon J, Myers DE, Uckun FM: Biotherapy for xenografted human central nervous system leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin. Blood 1995, 85:2537-2545.
35. Uckun FM, Evans WE, Forsyth CJ, Waddick KG, Ahlgren LT, Chelstrom LM, Burkhardt A, Bolen J, Myers DE: Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 1995, 267:886-891.
36. Clarke MF, Apel IJ, Benedict MA, Eipers PG, Sumantran V, Gonzalez-Garcia M, Doedens M, Fukunaga N, Davidson B, Dick JE, et al.: A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proc Natl Acad Sci U S A 1995, 92:11024-11028.
37. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri M, Dick JE: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648.
38. Haase D, Feuring-Buske M, Konemann S, Fonatsch C, Troff C, Verbeek W, Pekrun A, Hiddemann W, Wormann B: Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations. Blood 1995, 86:2906-2912.
39. Wetzler M, Talpaz M, Estrov Z, Kurzrock R: CML: mechanisms of disease initiation and progression [review]. Leuk Lymphoma 1993, 1:47-50.
40. Gale RP, Grosveld G, Canaani E, Goldman JM: Chronic myelogenous leukemia: biology and therapy. Leukemia 1993, 7:653-658.
41. Sirard C, Lapidot T, Vormoor J, Cashman J, Doedens M, Murdoch B, Jamal N, Messner H, Addey L, Minden M, Laraya P, Keating A, Eaves A, Lansdorp P, Eaves C, Dick J: Normal and leukemic SCID-repopulating cells (SRC) co-exist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 1996, 87:1539-1548. This paper describes a system for engrafting SCID mice with chronic-phase CML cells that will lay the foundation for an assay for CML stem cells. Moreover, this paper demonstrates that normal primitive repopulating cells are mobilized into the peripheral blood of patients with CML in addition to primitive CML cells.